Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation.
about
Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment)Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation.Drug development for the irritable bowel syndrome: current challenges and future perspectivesSerotonin contracts the rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels via the 5-HT2A receptor and Src tyrosine kinase.Weikangning therapy in functional dyspepsia and the protective role of Nrf2.
P2860
Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Safety and efficacy of tegaser ...... drome or chronic constipation.
@ast
Safety and efficacy of tegaser ...... drome or chronic constipation.
@en
type
label
Safety and efficacy of tegaser ...... drome or chronic constipation.
@ast
Safety and efficacy of tegaser ...... drome or chronic constipation.
@en
prefLabel
Safety and efficacy of tegaser ...... drome or chronic constipation.
@ast
Safety and efficacy of tegaser ...... drome or chronic constipation.
@en
P2093
P1476
Safety and efficacy of tegaser ...... ndrome or chronic constipation
@en
P2093
P304
P577
2010-04-20T00:00:00Z